Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

6.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.5K
The Two-State Receptor Model01:29

The Two-State Receptor Model

3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

8.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
8.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

45.5K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
45.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

7.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II-induced cAMP signalling.

British journal of pharmacology·2026
Same author

Quick Determination of Adrenal Venous Selectivity for the Determination of Unilateral Aldosteronism.

The Journal of clinical endocrinology and metabolism·2026
Same author

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

Cancer communications (London, England)·2025
Same author

Association Between Papillary Thyroid Cancer and Primary Aldosteronism in Individuals With Hypertension.

The Journal of clinical endocrinology and metabolism·2024
Same author

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

bioRxiv : the preprint server for biology·2024
Same author

An in Vitro triple screen model for human mineralocorticoid receptor activity.

The Journal of steroid biochemistry and molecular biology·2024

Related Experiment Video

Updated: Apr 28, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

11.9K

The multifaceted mineralocorticoid receptor.

Elise Gomez-Sanchez1, Celso E Gomez-Sanchez

  • 1G.V.(Sonny) Montgomery V.A. Medical Center and Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

Comprehensive Physiology
|June 20, 2014
PubMed
Summary

Balancing mineralocorticoid (MR) and glucocorticoid receptors (GRs) is vital for homeostasis. Disrupting this balance, particularly with MR antagonists, can negatively impact cognition, memory, and affect.

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

14.6K
Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
11:07

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding

Published on: September 21, 2011

14.3K

Related Experiment Videos

Last Updated: Apr 28, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

11.9K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

14.6K
Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
11:07

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding

Published on: September 21, 2011

14.3K

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Physiology

Background:

  • Aldosterone and glucocorticoids are primary adrenal steroid hormones acting via mineralocorticoid (MR) and glucocorticoid receptors (GRs).
  • These hormones are essential for homeostasis, stress response, inflammation control, and tissue repair.
  • MR and GR are co-expressed in many tissues, interacting functionally and molecularly.

Purpose of the Study:

  • To explore the intricate balance between MR and GR activation.
  • To understand the role of 11β-hydroxysteroid dehydrogenase enzymes (11β-HSDs) in regulating hormone access to receptors.
  • To investigate the consequences of MR antagonist use on normal MR/GR interactions.

Main Methods:

  • Review of existing literature on adrenal steroid hormones, MR, GR, and 11β-HSDs.
  • Analysis of the molecular mechanisms underlying MR and GR activation and interaction.
  • Discussion of the physiological and pathophysiological implications of MR/GR balance.

Main Results:

  • MR exhibits equal binding affinity for aldosterone, cortisol, and corticosterone.
  • 11β-HSD2 inactivates cortisol/corticosterone, enabling aldosterone to activate MR in target cells.
  • 11β-HSD1 typically activates cortisol/corticosterone, amplifying circulating levels.
  • Glucocorticoids activate MR at basal levels and GR at stress levels.
  • MR antagonists can mitigate inappropriate MR activation in cardiometabolic syndrome but may impair crucial MR/GR interactions.

Conclusions:

  • Maintaining the appropriate balance of MR and GR activation is critical for overall homeostasis.
  • Imbalances, exacerbated by MR antagonists, pose risks to neuronal functions including cognition, memory, and affect.
  • Further research is needed to fully elucidate the complex interplay between MR, GR, and 11β-HSDs.